-
Event / Presentation
2025.12.22
CEO Tomohiro Fujita Shares Insights on AI-Driven Bio-Production Strategy at FII PRIORITY Asia 2025
-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Event / Presentation
2025.11.28
CHITOSE to Present on Mammalian Cell Technologies at JAACT 2025 in Osaka
-
Event / Presentation
2025.11.11
CHITOSE Participated in BPI Asia 2025 and Co-Presented with Waters on Their Case Study
-
Event / Presentation
2025.10.14
CHITOSE to Attend CPHI Frankfurt and BIO-Europe 2025 to Forge New Biopharmaceutical Partnerships
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Event / Presentation
2025.06.03
CHITOSE Presents on Novel HAT Cell Line for AAV Manufacturing at ASGCT Annual Meeting
-
Event / Presentation
2025.05.14
CHITOSE Presented on CHO-MK Cells Establishment and Culture Strategy at Cell Culture Engineering XIX
-
Media / Editorial
2024.10.04
CHITOSE AI-Powered Bioproduction Management System Featured in Focus NEDO No. 92
